In a report released today, Lawrence Keusch from Raymond James maintained a Hold rating on Stericycle (SRCL). The company’s shares closed last Monday at $69.91.
According to TipRanks.com, Keusch is a 4-star analyst with an average return of 8.2% and a 69.4% success rate. Keusch covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, Baxter International, and Intuitive Surgical.
Stericycle has an analyst consensus of Moderate Buy, with a price target consensus of $79.25, implying a 13.2% upside from current levels. In a report issued on December 4, Barrington also initiated coverage with a Hold rating on the stock.
See today’s analyst top recommended stocks >>
Based on Stericycle’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $636 million and GAAP net loss of $81.2 million. In comparison, last year the company earned revenue of $833 million and had a GAAP net loss of $59.2 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Stericycle, Inc. engages in the provision of waste management services. It operates through the following segments: Domestic and Canada Regulated Waste and Compliance Services (RCS); International RCS; and Domestic CRS. The Domestic and Canada RCS segment manages medical and pharmaceutical waste disposal, hazardous wastes, and unused and expired inventory. The International RCS segment includes patient transport services. The Domestic Communication and Related Services segment consists of inbound/outbound communication, automated patient reminders, online scheduling, notifications, product retrievals, product returns, and quality audits. The company was founded in March 1989 and is headquartered in Lake Forest, IL.
